Cold medications for infants and children have come under scrutiny, causing disruption at the shelf
Sick babies and kids with runny noses and coughs continue to shed controversy on the cough and cold category, resulting in changes in the way over-the-counter products are marketed and sold. Even after the U.S. Food and Drug Administration’s 2007 investigation of the safety and efficacy of cold medications for children resulted in voluntary withdrawal of medications for infants and children under 2 and the subsequent relabeling of medications, the drug industry continues to respond to ...
SIGN IN TO ACCESS THIS ARTICLE
Registering for Premium Content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.